Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 129, Issue 1, Pages 388-405Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI98869
Keywords
-
Categories
Funding
- Lundbeck Foundation
- CSL Behring
- Fonden af 1870
- Robert Wehnerts og Kirsten Wehnerts Fond
- Aage Bangs Fond
- A. P. Moller Foundation for the Advancement of Medical Science (Fonden til Laegevidenskabens Fremme)
- Oda og Hans Svenningsens Fond
- Carlsberg Foundation
- Graduate School of Health, Aarhus University
Ask authors/readers for more resources
Hereditary angioedema (HAE) is an autosomal dominant disease characterized by recurrent edema attacks associated with morbidity and mortality. HAE results from variations in the SERPING1 gene that encodes the C1 inhibitor (C1INH), a serine protease inhibitor (serpin). Reduced plasma levels of C1INH lead to enhanced activation of the contact system, triggering high levels of bradykinin and increased vascular permeability, but the cellular mechanisms leading to low C1INH levels (20%-30% of normal) in heterozygous HAE type I patients remain obscure. Here, we showed that C1INH encoded by a subset of HAE-causing SERPING1 alleles affected secretion of normal C1INH protein in a dominant-negative fashion by triggering formation of protein-protein interactions between normal and mutant C1INH, leading to the creation of larger intracellular C1INH aggregates that were trapped in the endoplasmic reticulum (ER). Notably, intracellular aggregation of C1INH and ER abnormality were observed in fibroblasts from a heterozygous carrier of a dominant-negative SERPING1 gene variant, but the condition was ameliorated by viral delivery of the SERPING1 gene. Collectively, our data link abnormal accumulation of serpins, a hallmark of serpinopathies, with dominant-negative disease mechanisms affecting C1INH plasma levels in HAE type I patients, and may pave the way for new treatments of HAE.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available